Sign In
Buy HRTX
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
Heron Therapeutics to Present at Upcoming Investor Conferences
04:05pm, Thursday, 11'th Nov 2021
SAN DIEGO, Nov. 11, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treat
Heron Therapeutics, Inc. (HRTX) CEO Barry Quart on Q3 2021 Results - Earnings Call Transcript
09:13pm, Wednesday, 03'rd Nov 2021
Heron Therapeutics, Inc. (HRTX) CEO Barry Quart on Q3 2021 Results - Earnings Call Transcript
Bluebird Bio or Heron Therapeutics: Which Stock Is the Better Comeback Play?
10:00am, Monday, 11'th Oct 2021
These once-promising biotech stocks are trading at a fraction of their all-time highs right now.
Heron Therapeutics: Looking For Signs Of The Bottom
01:05am, Thursday, 07'th Oct 2021
After setbacks with the FDA, Heron finally launched Zynrelef in July with a constricted label to market. I believe Zynrelef might struggle in its first few quarters on the market. Heron is looking to
Heron Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference
04:05pm, Tuesday, 21'st Sep 2021
SAN DIEGO, Sept. 21, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class trea
Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates
10:50am, Monday, 09'th Aug 2021
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -5.08% and -21.08%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
SAN DIEGO, Aug. 9, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatm
SAN DIEGO, July 28, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatm
Heron Therapeutics' Zynrelef Shows Reduction In Post-Op Pain, Opioid Use Compared To Bupivacaine In Old-Aged Patients
07:19am, Thursday, 22'nd Jul 2021
Heron Therapeutics Inc (NASDAQ: HRTX) has announced the online publication of a new analysis from the Phase 3 EPOCH 1 and EPOCH 2 studies evaluating Zynrelef (bupivacaine and meloxicam) in adults a
SAN DIEGO, July 21, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatm
Heron Therapeutics Announces 340B Prime Vendor Contract with Apexus for ZYNRELEF™
08:30am, Tuesday, 06'th Jul 2021
SAN DIEGO, July 6, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treat
SAN DIEGO, July 1, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatme
Under Biden's Budget, These 2 Little-Known Biotechs Could Help End the Opioid Crisis
01:00pm, Wednesday, 02'nd Jun 2021
The White House's plans to address the U.S. opioid crisis could be good news for Heron Therapeutics and Collegium Pharmaceutical, makers of safer pain management drugs.
Heron Therapeutics to Present at the 2021 Jefferies Virtual Investor Conference
04:05pm, Tuesday, 25'th May 2021
SAN DIEGO, May 25, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatm
Trading Penny Stocks? 3 Biotech Stocks To Watch Before June 2021
11:47am, Tuesday, 25'th May 2021
Current & former penny stocks trading higher after surge of interest in biotech industry. The post Trading Penny Stocks?
